IOVANCE BIOTHERAPEUTICS, INC. Public Float
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) had Public Float of $534.80 million as of 2025-06-30, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-24
- 2025-06-30: Entity Public Float $534.80M.
- 2024-06-30: Entity Public Float $2.10B.
- 2023-06-30: Entity Public Float $1.40B.
- 2022-06-30: Entity Public Float $1.60B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $534.80M 10-K · filed 2026-02-24 |
| 2024-06-30 | $2.10B 10-K · filed 2025-02-27 |
| 2023-06-30 | $1.40B 10-K · filed 2024-02-28 |
| 2022-06-30 | $1.60B 10-K · filed 2023-02-28 |
| 2021-06-30 | $3.80B 10-K · filed 2022-02-24 |
| 2020-06-30 | $3.70B 10-K · filed 2021-02-25 |
| 2019-06-30 | $2.90B 10-K · filed 2020-02-25 |
| 2018-06-30 | $1.13B 10-K · filed 2019-02-28 |
| 2017-06-30 | $363.07M 10-K · filed 2018-03-12 |
| 2016-06-30 | $398.81M 10-K · filed 2017-03-09 |
| 2015-06-30 | $314.38M 10-K · filed 2016-03-11 |
| 2014-06-30 | $87.40M 10-K · filed 2015-03-16 |
| 2013-06-30 | $26.66M 10-K · filed 2014-03-28 |
| 2012-08-14 | $0.00 10-Q/A · filed 2012-09-10 |
| 2012-06-30 | $35.23M 10-K · filed 2013-09-23 |
| 2012-03-28 | $110.20M 10-K · filed 2012-03-30 |
| 2011-11-18 | $73.30M 10-Q · filed 2011-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |